CLDN18.2/HER2 CAR-NK cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CLDN18.2/HER2 CAR-NK cells, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer [Phase 1, Phase 2]